When was Brainomix founded?

Brainomix was founded in 2010 and raised its 1st funding round 4 years after it was founded.

Where is Brainomix located?

Brainomix is headquartered in Oxford, United Kingdom.

Who is the current CEO of Brainomix?

Michalis Papadakis of Brainomix. They have also founded 1 company.

Which legal entities is Brainomix associated with?

Brainomix is associated with BRAINOMIX LIMITED and 1 other.

How many employees does Brainomix have?

As of Jun 30, 2026, the latest employee count at Brainomix is 87.

Is Brainomix a funded company?

Brainomix is a funded company, having raised a total of $63.3M across 9 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Sep 26, 2014.

How much is Brainomix worth?

The latest valuation of Brainomix is £***** as of Oct 24, 2025.

When was the latest funding round of Brainomix?

Brainomix's latest funding was a $***** Series C round on Oct 24, 2025, with participation from 1 investor.

What is the annual revenue of Brainomix?

Annual revenue of Brainomix is between £1M and £10M as on Dec 31, 2025

Where does Brainomix rank among its competitors?

Brainomix ranks 2nd amongst 679 active competitors, of which 54 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Xenter, which secured $58.2M in Jun, 2026.

Who are the top competitors of Brainomix?

Brainomix's top competitors include Viz.ai, Infervision and Grand Rounds. Among them, Xenter secured the most recent funding round in June, 2026.

Brainomix - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Developer of automated medical imaging software for stroke and lung. This technology processes medical scans to identify biomarkers and assist in clinical assessment. The software provides automated analysis for stroke detection and lung disease evaluation. These tools support diagnostic workflows by generating insights from imaging data to assist in treatment decisions.

Website: www.brainomix.com/
Social
Email ID: *****@brainomix.com
Phone Number: +44 **********

Key Metrics

Founded Year

2010

Location

Oxford, United Kingdom

Stage

Series C

Total Funding

$63.3M in 9 rounds

Latest Funding Round

Series C, Oct 24, 2025, $*****

Post Money Valuation

£***** as on Oct 24, 2025

Investors

Parkwalk & 17 more

Ranked

2^nd among 679 active competitors

Annual Revenue

£1M - £10M as on Dec 31, 2025

Employee Count

87 as on Jun 30, 2026

Similar Companies

OpenEvidence & 3731 more

View Brainomix's full profile

Brainomix is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
BRAINOMIX LIMITED CIN: 7426406 , Germany, Active	Nov 01, 2010	£1M - £10M (As on Dec 31, 2025)	29 (As on Dec 31, 2019)
Brainomix Limited CIN: 0788.872.492 , Belgium, Active	Jul 01, 2022	-	-	-

Brainomix has raised a total funding of $63.3M over 9 rounds. Its first funding round was on Sep 26, 2014. Its latest funding round was a Series C round on Oct 24, 2025 for $*****. 1 investor participated in its latest round. Brainomix has 16 institutional investors and 2 angel investors.

Here is the list of recent funding rounds of Brainomix:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 24, 2025	6111456	Series C	3965380	9451527	6259340	9021737
Jan 06, 2025	9132910	Series C	9080548	3529679	3066711	IP Group
May 26, 2023	9132604	Series B	1838231	6445915	9823031	5952658

Access funding benchmarks and valuations. Sign up today!

View details of Brainomix's funding rounds and investors

The founders of Brainomix are Andrew Charles Barker, Michalis Papadakis and Michael Printzos. Michalis Papadakis is the CEO of Brainomix.

Here are the details of Brainomix's key team members:

Andrew Charles Barker: Former Co-Founder of Brainomix. They serve on the board of 1 company.
Michalis Papadakis: Co-Founder & CEO of Brainomix. They serve on the board of 1 company.
Contact Info: 1 email address
Michael Printzos: Co-founder of Brainomix.

Brainomix's Board of Directors

Brainomix's board has 6 active members. Andrew Charles Barker and Michalis Papadakis are part of team and Heinz-otto Peitgen, Ann Jacqueline Naylor, Mark Thomas Jaffray and Frank Kalkbrenner are independent board members.

Here is the list of Brainomix's board of directors:

Name	Type	Representing	Status	Duration
Andrew Charles Barker	Team	-	Current	12y 4m
Michalis Papadakis	Team	-	Current	15y 9m
Heinz-otto Peitgen	Independent board member	-	Current	6y 0m
hzhqokz	Independent board member	-	Current	8y 7m
hmymzok	Independent board member	-	Current	4y 2m
i{nyerp	Independent board member	-	Current	3y 1m
wbvjok{	Independent board member	-	Past	8y 5m

View details of Brainomix's Founder profiles and Board Members

Brainomix's employee count trend

Brainomix has 87 employees as of Jun 26. Here is Brainomix's employee count trend over the years:

Uncover Brainomix's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Brainomix include Viz.ai, Infervision and Grand Rounds. Here is the list of Top 10 competitors of Brainomix, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Viz.ai 2016, San Francisco (United States), Series D	Developer of an AI-powered platform for care coordination and disease detection	$252M	Insight Partners, Kleiner Perkins & 17 others	64/100
2nd	Brainomix 2010, Oxford (United Kingdom), Series C	Developer of automated medical imaging software for stroke and lung	$63.3M	Boehringer Ingelheim Venture Fund, IP Group ... & 16 others	63/100
3rd	Infervision 2016, Beijing (China), Series D	AI-based medical imaging and clinical diagnosis solutions	$213M	Goldman Sachs Investment Partners, CCB trust ... & 19 others	62/100
4th	Grand Rounds 2011, San Francisco (United States), Series D	Provider of virtual care, navigation, and support for healthcare needs	$230M	The Carlyle Group, BlackRock & 4 others	58/100
5th	HEALWELL AI 2012, Toronto (Canada), Acquired	AI-enabled decision support tool for healthcare providers	-	Eight Capital, VRG Capital	57/100
6th	Airdoc 2015, Beijing (China), Public	Offers decision support solutions	-	Lilly Asia Ventures, Ping An & 7 others	57/100
7th	Marathon 2005, Indianapolis (United States), Seed	Provider of advanced primary care and occupational health solutions for organizations	-	General Atlantic, New Enterprise Associates	55/100
8th	Surgical Safety 2014, New York City (United States), Series B	Provider of AI-based diagnosis and treatment solutions for healthcare organizations	$33.2M	USVP, Sante	52/100
9th	Arine 2017, San Francisco (United States), Series C	Medication management solution for healthcare professionals	$95M	111 West Capital, Katalyst Ventures & 10 others	51/100
10th	Xenter 2017, Draper (United States), Series B	Developer of wireless technologies for interventional medicine	$62.2M	Black Mountain Investment Group	51/100